-+ 0.00%
-+ 0.00%
-+ 0.00%

Niagen Bioscience Widens FY2026 Sales Guidance of $138.982M-$145.299M vs $141.072M Est

Benzinga·08/04/2026 20:06:26
语音播报
Niagen Bioscience (NASDAQ:NAGE) widens FY2026 sales outlook from $138.982 million-$145.299 million to $138.982 million-$145.299 million vs $141.072 million estimate.